EU Medtech Regulatory Overhaul Calls For Major Business Strategy Rethink

The EU’s medical device regulatory structure, first devised over 20 years ago, is starting to change. The first major revision of directives will produce a tougher environment and require medtech manufacturers to make some significant adjustments.

More from Global Vision

More from In Vivo